Boston-based Beta Bionics, whose automated insulin dosing software the FDA approved in May 2023, raised a $100M Series D, taking its total funding to $293.5M (Andrea Park/Fierce Biotech)



Andrea Park / Fierce Biotech:

Boston-based Beta Bionics, whose automated insulin dosing software the FDA approved in May 2023, raised a $100M Series D, taking its total funding to $293.5M  —  In the wake of earning FDA clearance for its insulin pump an |  In the wake of earning FDA clearance for its insulin pump …



About WN

Check Also

L’Oreal Professionnel AirLight Pro Review: Faster, Lighter, and Repairable

AirLight is compatible with iOS 13.0 and above (including iPads), Android 8.0 Oreo and above, …

Advertisment ad adsense adlogger